Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy
Inflammation plays a key role in cardiovascular disease by contributing to atherothrombosis. The PLATelet inhibition and patient Outcomes (PLATO) study (NCT00391872) compared ticagrelor to clopidogrel in patients with acute coronary syndromes and demonstrated fewer cardiovascular events with ticagre...
Autors principals: | Thomas A. Nelson, William A.E. Parker, Tatevik Ghukasyan Lakic, Johan Westerbergh, Stefan K. James, Agneta Siegbahn, Richard C. Becker, Anders Himmelmann, Lars Wallentin, Robert F. Storey |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Taylor & Francis Group
2022-04-01
|
Col·lecció: | Platelets |
Matèries: | |
Accés en línia: | http://dx.doi.org/10.1080/09537104.2021.1934667 |
Ítems similars
-
INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
per: E. V. Tavlueva, et al.
Publicat: (2017-11-01) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
per: Candice Volney, et al.
Publicat: (2019-07-01) -
Clinical outcomes with the use of ticagrelor or clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction – A prospective observational study
per: Bibek Agarwal, et al.
Publicat: (2022-01-01) -
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
per: Stylianos Petousis, et al.
Publicat: (2022-07-01) -
The Effect of Ticagrelor for Endovascular Intervention of Intracranial Aneurysm Patients with or without Clopidogrel Resistant: A Meta-Analysis
per: Pengfei Xia, et al.
Publicat: (2022-08-01)